NEWHAM VICARAGE PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: F84077 | LONDON, E15 4ES
Showing results 351-400 of 518
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Chlorhexidine gluconate | 27 | 8,100 | £63 | +22.9% ▲ |
| Adapalene | 27 | 1,215 | £422 | +23.4% ▲ |
| Canagliflozin | 26 | 1,502 | £1.9K | -81.9% ▼ |
| Tibolone | 26 | 1,092 | £99 | -15.0% ▼ |
| Sevelamer | 26 | 3,816 | £619 | +18.7% ▲ |
| Clindamycin phosphate | 26 | 1,200 | £254 | +58.1% ▲ |
| 26 | 1,130 | £580 | -11.5% ▼ | |
| Sennosides | 25 | 15.0K | £277 | -19.0% ▼ |
| Bumetanide | 25 | 3,920 | £384 | -90.8% ▼ |
| Irbesartan with diuretic | 25 | 1,652 | £331 | +58.9% ▲ |
| Tiotropium bromide/olodaterol | 25 | 36 | £1.1K | -59.2% ▼ |
| Haloperidol | 25 | 984 | £1.8K | -47.5% ▼ |
| Glimepiride | 25 | 2,368 | £65 | -72.9% ▼ |
| Testosterone | 25 | 1,705 | £749 | -67.2% ▼ |
| Clindamycin/tretinoin | 25 | 840 | £318 | +113.0% ▲ |
| Terbutaline sulphate | 24 | 34 | £268 | -55.7% ▼ |
| Zuclopenthixol decanoate | 24 | 61 | £185 | +49.5% ▲ |
| Tacrolimus | 24 | 1,750 | £2.8K | -10.3% ▼ |
| Ciclosporin (Eye Anti Inflammatory) | 24 | 810 | £1.9K | -3.2% ▼ |
| 24 | 24 | £130 | -53.2% ▼ | |
| 24 | 650 | £3.0K | +184.4% ▲ | |
| Methyldopa | 23 | 4,480 | £952 | +35.0% ▲ |
| Olmesartan medoxomil | 23 | 1,260 | £44 | -66.6% ▼ |
| Vortioxetine | 23 | 1,092 | £1.0K | -66.9% ▼ |
| Clonidine hydrochloride | 23 | 2,576 | £252 | -56.9% ▼ |
| Insulin degludec | 23 | 97 | £905 | -79.1% ▼ |
| Ready to serve 4.5 - 5 kcal/ml energy (fat) liquid (0913142) | 23 | 60.6K | £1.7K | +105.1% ▲ |
| 23 | 1,284 | £118 | -71.4% ▼ | |
| Nebivolol | 22 | 1,008 | £131 | -79.2% ▼ |
| Zolpidem tartrate | 22 | 322 | £15 | -75.6% ▼ |
| Erythromycin | 22 | 1,596 | £538 | -36.5% ▼ |
| Erythromycin ethylsuccinate | 22 | 2,600 | £236 | -5.8% ▼ |
| Cinacalcet hydrochloride | 22 | 1,036 | £263 | -5.2% ▼ |
| Betamethasone sodium phosphate | 22 | 310 | £71 | -15.1% ▼ |
| 22 | 330 | £39 | -18.1% ▼ | |
| Co-magaldrox (Magnesium/aluminium hydroxide) | 21 | 10.5K | £60 | +159.2% ▲ |
| Olmesartan medoxomil/amlodipine/hydrochlorothiazide | 21 | 560 | £324 | +32.8% ▲ |
| Desloratadine | 21 | 2,200 | £206 | -27.2% ▼ |
| Mebendazole | 21 | 360 | £24 | +83.4% ▲ |
| 21 | 1,125 | £112 | +59.2% ▲ | |
| Semaglutide | 20 | 722 | £2.0K | -91.7% ▼ |
| Powder delisted probiotic (0913531) | 20 | 600 | £757 | +192.7% ▲ |
| Bimatoprost | 20 | 117 | £348 | -86.5% ▼ |
| Zinc oxide | 20 | 2,985 | £100 | -0.5% vs avg |
| Amorolfine hydrochloride | 20 | 115 | £138 | -13.4% ▼ |
| 20 | 205 | £560 | +27.4% ▲ | |
| 20 | 3,550 | £506 | -48.6% ▼ | |
| 20 | 750 | £1.2K | +22.5% ▲ | |
| Ursodeoxycholic acid | 19 | 3,088 | £1.2K | -71.3% ▼ |
| Bempedoic acid | 19 | 756 | £1.4K | -42.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.